Medtech firm Stryker plans to buy device maker Inari Medical for $4.9 billion
MLex Summary: Stryker, a publicly traded firm that sells a variety of medical technologies, plans to pay $80 per share to acquire Inari Medical, a biotech firm that specializes in creating...To view the full article, register now.
Already a subscriber? Click here to view full article